Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE ...

A higher proportion of adolescents who tested positive for COVID-19 reported ongoing symptoms compared with those who tested negative or never tested.

The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies neutralize the intended SARS-CoV-2 variant.

The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously ...

“Our findings suggest that cancer survivors may be at increased risk of metastatic relapse after common respiratory viral ...

For 50 years, the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan has helped producers ...

Violet Affleck, Ben Affleck and Jennifer Garner's eldest daughter, joined global leaders for the Healthy Indoor Air event at the U.N. headquarters in New York City.

Expert consensus outlines diagnostic and therapeutic strategies for managing SARS-CoV-2 infection in solid organ transplant ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

Immune profiles after COVID-19 vaccination predict booster need, with rapid-decliners at higher risk of breakthrough ...

Moderna said on Tuesday its updated COVID-19 vaccine elicited a strong immune response in all adults age 65 and older, as ...

New federal vaccination guidance created uncertainties about how most Americans can get their COVID-19 vaccines this fall.